source
- Myriad Genetics sells prenatal testing business to Labcorp for $210 millionMyriad Genetics announced it will divest its Prenatal Health testing division to Labcorp, receiving $210 million in cash. The transaction includes Myriad's Prequel, Foresight, SneakPeek and FirstG…
- China biotech RiboX reports first human data for circular RNA therapiesChina biotech company RiboX has disclosed its initial human data on circular RNA therapeutics, marking the first clinical readout for this emerging platform. The study represents a milestone for t…